Specific protein degradation is remaining explored in its place approach in cancer, whereby the all-natural protein degradation system is co-opted for therapeutic purposes. Lately created novel molecules termed proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One particular ligand binds to the ‘protein of https://www.directivepublications.org/journal-of-clinical-breast-cancer/